These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31136762)

  • 1. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
    Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
    Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
    Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
    Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
    Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
    Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
    Yamagishi Y; Tessier-Lavigne M
    Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of NMNAT2 compromise axon development and survival.
    Gilley J; Mayer PR; Yu G; Coleman MP
    Hum Mol Genet; 2019 Feb; 28(3):448-458. PubMed ID: 30304512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
    Milde S; Gilley J; Coleman MP
    Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia.
    Huppke P; Wegener E; Gilley J; Angeletti C; Kurth I; Drenth JPH; Stadelmann C; Barrantes-Freer A; Brück W; Thiele H; Nürnberg P; Gärtner J; Orsomando G; Coleman MP
    Exp Neurol; 2019 Oct; 320():112958. PubMed ID: 31132363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.
    Gilley J; Adalbert R; Yu G; Coleman MP
    J Neurosci; 2013 Aug; 33(33):13410-24. PubMed ID: 23946398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
    Milde S; Fox AN; Freeman MR; Coleman MP
    Sci Rep; 2013; 3():2567. PubMed ID: 23995269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMNAT2: An important metabolic enzyme affecting the disease progression.
    Li W; Gao M; Hu C; Chen X; Zhou Y
    Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
    Shen H; Hyrc KL; Goldberg MP
    Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
    Conforti L; Gilley J; Coleman MP
    Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide Mononucleotide Adenylyltransferase 2 maintains neuronal structural integrity through the maintenance of golgi structure.
    Pottorf T; Mann A; Fross S; Mansel C; Vohra BPS
    Neurochem Int; 2018 Dec; 121():86-97. PubMed ID: 30278188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
    Yahata N; Yuasa S; Araki T
    J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo.
    Hicks AN; Lorenzetti D; Gilley J; Lu B; Andersson KE; Miligan C; Overbeek PA; Oppenheim R; Bishop CE
    PLoS One; 2012; 7(10):e47869. PubMed ID: 23082226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity.
    Zhai RG; Cao Y; Hiesinger PR; Zhou Y; Mehta SQ; Schulze KL; Verstreken P; Bellen HJ
    PLoS Biol; 2006 Nov; 4(12):e416. PubMed ID: 17132048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A local mechanism mediates NAD-dependent protection of axon degeneration.
    Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
    J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.